<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37189452</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>21</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>Deregulation of Plasma microRNA Expression in a <i>TARDBP</i>-ALS Family.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">706</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom13040706</ELocationID><Abstract><AbstractText>TDP-43 intracellular aggregates are a pathogenic sign of most amyotrophic lateral sclerosis (ALS) cases. Familial ALS, brought on by <i>TARDBP</i> gene mutations, emphasizes the relevance of this altered protein in pathophysiology. Growing evidence suggests a role for dysregulated microRNA (miRNA) in ALS disease. Furthermore, several studies showed that miRNAs are highly stable in various biological fluids (CSF, blood, plasma, and serum), and they are expressed differentially by comparing ALS patients and controls. In 2011, our research group discovered a rare mutation in a <i>TARDBP</i> gene (G376D) in a large ALS Apulian family with affected members exhibiting a rapidly progressing disease. To identify potential non-invasive biomarkers of preclinical and clinical progression in the <i>TARDBP</i>-ALS family, we assessed the expression levels of plasma microRNAs in affected patients (n = 7) and asymptomatic mutation carriers (n = 7) compared with healthy controls (n = 13). Applying qPCR, we investigate 10 miRNAs that bind TDP-43 in vitro during their biogenesis or in their mature form, and the other nine are known to be deregulated in the disease. We highlight the potential of miR-132-5p, miR-132-3p, miR-124-3p, and miR-133a-3p expression levels in plasma as biomarkers of preclinical progression for G376D-<i>TARDBP</i>-associated ALS. Our research strongly supports the potential of plasma miRNAs as biomarkers for performing predictive diagnostics and identifying new therapeutic targets.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ruffo</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Medical Genetics Laboratory, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catalano</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Bella</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-2045-1864</Identifier><AffiliationInfo><Affiliation>ALS Clinical Research Centre and Laboratory of Neurochemistry, Department of Experimental Biomedicine and Clinical Neurosciences, University of Palermo, 90133 Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conforti</LastName><ForeName>Francesca Luisa</ForeName><Initials>FL</Initials><Identifier Source="ORCID">0000-0001-8364-1783</Identifier><AffiliationInfo><Affiliation>Medical Genetics Laboratory, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TARDBP</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">different expression</Keyword><Keyword MajorTopicYN="N">microRNA</Keyword><Keyword MajorTopicYN="N">mutation carriers</Keyword><Keyword MajorTopicYN="N">plasma</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>16</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37189452</ArticleId><ArticleId IdType="pmc">PMC10135769</ArticleId><ArticleId IdType="doi">10.3390/biom13040706</ArticleId><ArticleId IdType="pii">biom13040706</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Mead R.J., Shan N., Reiser H.J., Marshall F., Shaw P.J. Amyotrophic lateral sclerosis: A neurodegenerative disorder poised for successful therapeutic translation. Nat. Rev. Drug Discov. 2023;22:185&#x2013;212. doi: 10.1038/s41573-022-00612-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-022-00612-2</ArticleId><ArticleId IdType="pmc">PMC9768794</ArticleId><ArticleId IdType="pubmed">36543887</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungaro C., Sprovieri T., Morello G., Perrone B., Spampinato A.G., Simone I.L., Trojsi F., Monsurro M.R., Spataro R., La Bella V., et al. Genetic investigation of amyotrophic lateral sclerosis patients in south Italy: A two-decade analysis. Neurobiol. Aging. 2021;99:99.e7&#x2013;99.e14. doi: 10.1016/j.neurobiolaging.2020.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2020.08.017</ArticleId><ArticleId IdType="pubmed">32951934</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal N.A., Berry J.D., Windebank A., Staff N.P., Maragakis N.J., van den Berg L.H., Genge A., Miller R., Baloh R.H., Kern R., et al. Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS. Muscle Nerve. 2020;62:156&#x2013;166. doi: 10.1002/mus.26801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26801</ArticleId><ArticleId IdType="pmc">PMC7496557</ArticleId><ArticleId IdType="pubmed">31899540</ArticleId></ArticleIdList></Reference><Reference><Citation>Gros-Louis F., Gaspar C., Rouleau G.A. Genetics of familial and sporadic amyotrophic lateral sclerosis. Biochim. Biophys. Acta. 2006;1762:956&#x2013;972. doi: 10.1016/j.bbadis.2006.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.01.004</ArticleId><ArticleId IdType="pubmed">16503123</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2032;Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Jr., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S., Elamin M., Bede P., Shatunov A., Walsh C., Corr B., Heverin M., Jordan N., Kenna K., Lynch C., et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: A population-based cohort study. Lancet Neurol. 2012;11:232&#x2013;240. doi: 10.1016/S1474-4422(12)70014-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70014-5</ArticleId><ArticleId IdType="pmc">PMC3315021</ArticleId><ArticleId IdType="pubmed">22305801</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y., Mieda-Sato A. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc. Natl. Acad. Sci. USA. 2012;109:3347&#x2013;3352. doi: 10.1073/pnas.1112427109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1112427109</ArticleId><ArticleId IdType="pmc">PMC3295278</ArticleId><ArticleId IdType="pubmed">22323604</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L., World Federation of Neurology Research Group on Motor Neuron Diseases El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho M.D., Swash M. Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis. Amyotroph. Lateral Scler. 2009;10:53&#x2013;57. doi: 10.1080/17482960802521126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802521126</ArticleId><ArticleId IdType="pubmed">18985466</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannaford A., Pavey N., van den Bos M., Geevasinga N., Menon P., Shefner J.M., Kiernan M.C., Vucic S. Diagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral Sclerosis. Ann. Neurol. 2021;89:979&#x2013;986. doi: 10.1002/ana.26045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26045</ArticleId><ArticleId IdType="pubmed">33565111</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturmey E., Malaspina A. Blood biomarkers in ALS: Challenges, applications and novel frontiers. Acta Neurol. Scand. 2022;146:375&#x2013;388. doi: 10.1111/ane.13698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.13698</ArticleId><ArticleId IdType="pmc">PMC9828487</ArticleId><ArticleId IdType="pubmed">36156207</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M., Granit V., Andersen P.M., Grignon A.L., McHutchison C., Cosentino S., Malaspina A., Wuu J. Mild motor impairment as prodromal state in amyotrophic lateral sclerosis: A new diagnostic entity. Brain. 2022;145:3500&#x2013;3508. doi: 10.1093/brain/awac185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac185</ArticleId><ArticleId IdType="pmc">PMC9586537</ArticleId><ArticleId IdType="pubmed">35594156</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy B., Lee E., Li T., Rampersaud M. Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics. Genes. 2022;13:425. doi: 10.3390/genes13030425.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes13030425</ArticleId><ArticleId IdType="pmc">PMC8951370</ArticleId><ArticleId IdType="pubmed">35327979</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile G., Morello G., La Cognata V., Guarnaccia M., Conforti F.L., Cavallaro S. Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases. J. Pers. Med. 2022;12:770. doi: 10.3390/jpm12050770.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12050770</ArticleId><ArticleId IdType="pmc">PMC9143965</ArticleId><ArticleId IdType="pubmed">35629192</ArticleId></ArticleIdList></Reference><Reference><Citation>Panio A., Cava C., D&#x2032;Antona S., Bertoli G., Porro D. Diagnostic Circulating miRNAs in Sporadic Amyotrophic Lateral Sclerosis. Front. Med. 2022;9:861960. doi: 10.3389/fmed.2022.861960.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.861960</ArticleId><ArticleId IdType="pmc">PMC9121628</ArticleId><ArticleId IdType="pubmed">35602517</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834&#x2013;838. doi: 10.1038/nature03702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03702</ArticleId><ArticleId IdType="pubmed">15944708</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber J.A., Baxter D.H., Zhang S., Huang D.Y., Huang K.H., Lee M.J., Galas D.J., Wang K. The microRNA spectrum in 12 body fluids. Clin. Chem. 2010;56:1733&#x2013;1741. doi: 10.1373/clinchem.2010.147405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2010.147405</ArticleId><ArticleId IdType="pmc">PMC4846276</ArticleId><ArticleId IdType="pubmed">20847327</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruffo P., Strafella C., Cascella R., Caputo V., Conforti F.L., Ando S., Giardina E. Deregulation of ncRNA in Neurodegenerative Disease: Focus on circRNA, lncRNA and miRNA in Amyotrophic Lateral Sclerosis. Front. Genet. 2021;12:784996. doi: 10.3389/fgene.2021.784996.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2021.784996</ArticleId><ArticleId IdType="pmc">PMC8674781</ArticleId><ArticleId IdType="pubmed">34925464</ArticleId></ArticleIdList></Reference><Reference><Citation>Conforti F.L., Sproviero W., Simone I.L., Mazzei R., Valentino P., Ungaro C., Magariello A., Patitucci A., La Bella V., Sprovieri T., et al. TARDBP gene mutations in south Italian patients with amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2011;82:587&#x2013;588. doi: 10.1136/jnnp.2009.198309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.198309</ArticleId><ArticleId IdType="pubmed">20959352</ArticleId></ArticleIdList></Reference><Reference><Citation>Czell D., Andersen P.M., Morita M., Neuwirth C., Perren F., Weber M. Phenotypes in Swiss patients with familial ALS carrying TARDBP mutations. Neurodegener. Dis. 2013;12:150&#x2013;155. doi: 10.1159/000345835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000345835</ArticleId><ArticleId IdType="pubmed">23327806</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsuzawa S., Akiyama T., Nishiyama A., Suzuki N., Kato M., Warita H., Izumi R., Osana S., Koyama S., Kato T., et al. TARDBP p.G376D mutation, found in rapid progressive familial ALS, induces mislocalization of TDP-43. eNeurologicalSci. 2018;11:20&#x2013;22. doi: 10.1016/j.ensci.2018.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ensci.2018.04.001</ArticleId><ArticleId IdType="pmc">PMC6006914</ArticleId><ArticleId IdType="pubmed">29928714</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45. doi: 10.1093/nar/29.9.e45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/29.9.e45</ArticleId><ArticleId IdType="pmc">PMC55695</ArticleId><ArticleId IdType="pubmed">11328886</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C., Roos P.M., Piehl F., Kamel F., Fang F. Risk factors for amyotrophic lateral sclerosis. Clin. Epidemiol. 2015;7:181&#x2013;193. doi: 10.2147/CLEP.S37505.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S37505</ArticleId><ArticleId IdType="pmc">PMC4334292</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., De Conti L., Stuani C., Romano M., Baralle M., Baralle F. Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J. 2010;277:2268&#x2013;2281. doi: 10.1111/j.1742-4658.2010.07643.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2010.07643.x</ArticleId><ArticleId IdType="pubmed">20423455</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Muller K., Ludolph A.C., Weishaupt J.H. Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2013;1:42. doi: 10.1186/2051-5960-1-42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-1-42</ArticleId><ArticleId IdType="pmc">PMC3893596</ArticleId><ArticleId IdType="pubmed">24252274</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagkouni D., Paraskevopoulou M.D., Chatzopoulos S., Vlachos I.S., Tastsoglou S., Kanellos I., Papadimitriou D., Kavakiotis I., Maniou S., Skoufos G., et al. DIANA-TarBase v8: A decade-long collection of experimentally supported miRNA-gene interactions. Nucleic Acids Res. 2018;46:D239&#x2013;D245. doi: 10.1093/nar/gkx1141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1141</ArticleId><ArticleId IdType="pmc">PMC5753203</ArticleId><ArticleId IdType="pubmed">29156006</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Muller K., Zondler L., Weydt P., Volk A.E., Bozic A.L., Walter M., Bonin M., Mayer B., von Arnim C.A., et al. Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers. Brain. 2014;137:2938&#x2013;2950. doi: 10.1093/brain/awu249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu249</ArticleId><ArticleId IdType="pubmed">25193138</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Muller K., Zondler L., Weydt P., Mayer B., von Arnim C.A., Hubers A., Dorst J., Otto M., Holzmann K., et al. Serum microRNAs in sporadic amyotrophic lateral sclerosis. Neurobiol. Aging. 2015;36:2660.e15&#x2013;2660.e20. doi: 10.1016/j.neurobiolaging.2015.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.06.003</ArticleId><ArticleId IdType="pubmed">26142125</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanet A., Tacheny A., Arnould T., Renard P. miR-212/132 expression and functions: Within and beyond the neuronal compartment. Nucleic Acids Res. 2012;40:4742&#x2013;4753. doi: 10.1093/nar/gks151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks151</ArticleId><ArticleId IdType="pmc">PMC3367188</ArticleId><ArticleId IdType="pubmed">22362752</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15&#x2013;20. doi: 10.1016/j.cell.2004.12.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2004.12.035</ArticleId><ArticleId IdType="pubmed">15652477</ArticleId></ArticleIdList></Reference><Reference><Citation>Vacchiano V., Mastrangelo A., Zenesini C., Masullo M., Quadalti C., Avoni P., Polischi B., Cherici A., Capellari S., Salvi F., et al. Plasma and CSF Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: A Cross-Sectional and Longitudinal Study. Front. Aging Neurosci. 2021;13:753242. doi: 10.3389/fnagi.2021.753242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.753242</ArticleId><ArticleId IdType="pmc">PMC8569186</ArticleId><ArticleId IdType="pubmed">34744694</ArticleId></ArticleIdList></Reference><Reference><Citation>Poesen K., Van Damme P. Diagnostic and Prognostic Performance of Neurofilaments in ALS. Front. Neurol. 2018;9:1167. doi: 10.3389/fneur.2018.01167.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.01167</ArticleId><ArticleId IdType="pmc">PMC6345692</ArticleId><ArticleId IdType="pubmed">30713520</ArticleId></ArticleIdList></Reference><Reference><Citation>Morlando M., Dini Modigliani S., Torrelli G., Rosa A., Di Carlo V., Caffarelli E., Bozzoni I. FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment. EMBO J. 2012;31:4502&#x2013;4510. doi: 10.1038/emboj.2012.319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.319</ArticleId><ArticleId IdType="pmc">PMC3545295</ArticleId><ArticleId IdType="pubmed">23232809</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R., Wyles M., Heath P.R., Kazoka M., Wollff H., Shaw P.J., Kirby J. Small RNA Sequencing of Sporadic Amyotrophic Lateral Sclerosis Cerebrospinal Fluid Reveals Differentially Expressed miRNAs Related to Neural and Glial Activity. Front. Neurosci. 2017;11:731. doi: 10.3389/fnins.2017.00731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00731</ArticleId><ArticleId IdType="pmc">PMC5767269</ArticleId><ArticleId IdType="pubmed">29375285</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 2002;12:735&#x2013;739. doi: 10.1016/S0960-9822(02)00809-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(02)00809-6</ArticleId><ArticleId IdType="pubmed">12007417</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim S.E., Lim C.S., Kim J.I., Seo D., Chun H., Yu N.K., Lee J., Kang S.J., Ko H.G., Choi J.H., et al. The Brain-Enriched MicroRNA miR-9-3p Regulates Synaptic Plasticity and Memory. J. Neurosci. 2016;36:8641&#x2013;8652. doi: 10.1523/JNEUROSCI.0630-16.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0630-16.2016</ArticleId><ArticleId IdType="pmc">PMC6601897</ArticleId><ArticleId IdType="pubmed">27535911</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Wang X. Systematic identification of microRNA functions by combining target prediction and expression profiling. Nucleic Acids Res. 2006;34:1646&#x2013;1652. doi: 10.1093/nar/gkl068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkl068</ArticleId><ArticleId IdType="pmc">PMC1405822</ArticleId><ArticleId IdType="pubmed">16549876</ArticleId></ArticleIdList></Reference><Reference><Citation>Han D., Dong X., Zheng D., Nao J. MiR-124 and the Underlying Therapeutic Promise of Neurodegenerative Disorders. Front. Pharmacol. 2019;10:1555. doi: 10.3389/fphar.2019.01555.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.01555</ArticleId><ArticleId IdType="pmc">PMC6978711</ArticleId><ArticleId IdType="pubmed">32009959</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaz A.R., Vizinha D., Morais H., Colaco A.R., Loch-Neckel G., Barbosa M., Brites D. Overexpression of miR-124 in Motor Neurons Plays a Key Role in ALS Pathological Processes. Int. J. Mol. Sci. 2021;22:6128. doi: 10.3390/ijms22116128.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22116128</ArticleId><ArticleId IdType="pmc">PMC8201298</ArticleId><ArticleId IdType="pubmed">34200161</ArticleId></ArticleIdList></Reference><Reference><Citation>Matamala J.M., Arias-Carrasco R., Sanchez C., Uhrig M., Bargsted L., Matus S., Maracaja-Coutinho V., Abarzua S., van Zundert B., Verdugo R., et al. Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis. Neurobiol. Aging. 2018;64:123&#x2013;138. doi: 10.1016/j.neurobiolaging.2017.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.12.020</ArticleId><ArticleId IdType="pubmed">29458840</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Pi J., Zou D., Wang X., Xu J., Yu S., Zhang T., Li F., Zhang X., Zhao H., et al. microRNA arm-imbalance in part from complementary targets mediated decay promotes gastric cancer progression. Nat. Commun. 2019;10:4397. doi: 10.1038/s41467-019-12292-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12292-5</ArticleId><ArticleId IdType="pmc">PMC6764945</ArticleId><ArticleId IdType="pubmed">31562301</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Zhang R., Xu R., Shang J., He H., Yang Q. MicroRNA-574-5p in gastric cancer cells promotes angiogenesis by targeting protein tyrosine phosphatase non-receptor type 3 (PTPN3) Gene. 2020;733:144383. doi: 10.1016/j.gene.2020.144383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2020.144383</ArticleId><ArticleId IdType="pubmed">31972307</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Bigio E.H., Ince P.G., Geser F., Neumann M., Cairns N.J., Kwong L.K., Forman M.S., Ravits J., Stewart H., et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 2007;61:427&#x2013;434. doi: 10.1002/ana.21147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21147</ArticleId><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Boudreau R.L., Jiang P., Gilmore B.L., Spengler R.M., Tirabassi R., Nelson J.A., Ross C.A., Xing Y., Davidson B.L. Transcriptome-wide discovery of microRNA binding sites in human brain. Neuron. 2014;81:294&#x2013;305. doi: 10.1016/j.neuron.2013.10.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.10.062</ArticleId><ArticleId IdType="pmc">PMC4108341</ArticleId><ArticleId IdType="pubmed">24389009</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>